BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-10 out of 10 found
  Current Search:  efudex: 10     

HTML
100%
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Generic Equivalent to Valeants Efudex Topical Cream 5% HAWTHORNE, N.Y.-- (BUSINESS WIRE) -- Taro Pharmaceutical Industries Ltd.

('Taro' or the 'Company,' Pink Sheets: TAROF) today reported that it received approval from the U.S.

Food and Drug...

SmartBrief:  Mar 10 2010 9:06AM
Matching: efudex
Find similar documents
HTML
100%
BRIEF: Taro gets FDA approval for anti-cancer cream: The equivalent branded treatment had sales of $70 million in the US in 2009
Taro Pharmaceutical Industries Ltd.

(Pink Sheets: TAROF) today reported that it received approval from the US Food and Drug Administration (FDA) for fluorouracil cream.

Fluorouracil is bioequivalent to Efudex Topical Cream 5 percent manufactured by...

TradingMarkets:  Mar 10 2010 7:35AM
Matching: efudex
Find similar documents
HTML
100%
Taro Pharmaceutical wins FDA approval for fluorouracil cream
(Datamonitor via COMTEX) Taro Pharmaceutical Industries has received the FDA's approval of its abbreviated new drug application for fluorouracil topical cream USP, 5%, fluorouracil cream.

According to Taro Pharmaceutical Industries, its fluorouracil cream is...

Pharmacy Choice:  Mar 10 2010 11:39PM
Matching: efudex
Find similar documents
HTML
100%
Taro Pharmaceutical wins FDA approval for fluorouracil cream
Taro Pharmaceutical Industries has received the FDA's approval of its abbreviated new drug application for fluorouracil topical cream USP, 5%, fluorouracil cream.

According to Taro Pharmaceutical Industries, its fluorouracil cream is a prescription...

TradingMarkets:  Mar 10 2010 3:23PM
Matching: efudex
Find similar documents
HTML
100%
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Generic Equivalent to Valeant's Efudex Topical Cream 5% HAWTHORNE, N.Y.--(BUSINESS WIRE)--Mar 8, 2010 - Taro Pharmaceutical Industries Ltd.

(Taro or the Company, Pink Sheets: TAROF) today reported that it received approval from the U.S.

Food and Drug...

Pharma Live:  Mar 9 2010 7:17AM
Matching: efudex
Find similar documents
HTML
100%
3/8/10 - Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Generic Equivalent to Valeant's Efudex Topical Cream 5% HAWTHORNE, N.Y.(BUSINESS WIRE) Taro Pharmaceutical Industries Ltd.

(Taro?

or the Company,?

Pink Sheets: TAROF) today reported that it received approval from the U.S?

Food and Drug...

Pharmacy Choice:  Mar 9 2010 7:10AM
Matching: efudex
Find similar documents
HTML
100%
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Generic Equivalent to Valeant's Efudex Topical Cream 5% HAWTHORNE, N.Y.(BUSINESS WIRE) Taro Pharmaceutical Industries Ltd.

(Taro?

or the Company,?

Pink Sheets: TAROF) today reported that it received approval from the U.S?

Food and Drug...

Pharmacy Choice:  Mar 9 2010 2:19AM
Matching: efudex
Find similar documents
HTML
100%
Taro gets FDA approval for anti-cancer cream
The equivalent branded treatment had sales of $70 million in the US in 2009.

Taro Pharmaceutical Industries Ltd.(Pink Sheets: TAROF) today reported that it received approval from the US Food and Drug Administration (FDA) for fluorouracil cream.

Fluorouracil...

Globes:  Mar 9 2010 1:46PM
Matching: efudex
Find similar documents
HTML
100%
FDA approves Taro Pharmaceutical Industries' Fluorouracil Topical Cream ANDA
Taro Pharmaceutical Industries Ltd.

(Taro or the Company, Pink Sheets: TAROF) today reported that it received approval from the U.S.

Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Fluorouracil Topical Cream USP, 5% ...

News-Medical.Net:  Mar 9 2010 4:34AM
Matching: efudex
Find similar documents
HTML
100%
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Taro Pharmaceutical Industries Ltd.

(Taro or the Company, Pink Sheets: TAROF) today reported that it received approval from the U.S.

Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Fluorouracil Topical Cream USP, 5% ...

Genetic Engineering News:  Mar 8 2010 6:33PM
Matching: efudex
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.